2021
Oral Vancomycin or Ursodeoxycholic Acid for Pediatric Primary Sclerosing Cholangitis? The Uncontroversial Need for Randomized Controlled Trials
Assis DN, Levy C. Oral Vancomycin or Ursodeoxycholic Acid for Pediatric Primary Sclerosing Cholangitis? The Uncontroversial Need for Randomized Controlled Trials. Hepatology 2021, 73: 887-889. PMID: 33403699, DOI: 10.1002/hep.31702.Peer-Reviewed Original ResearchMeSH KeywordsChildCholagogues and CholereticsCholangitis, SclerosingHumansRandomized Controlled Trials as TopicUrsodeoxycholic AcidVancomycin
2016
The interpretation of hepatic venous pressure gradient tracings – excellent interobserver agreement unrelated to experience
Tandon P, Ripoll C, Assis D, Wongcharatrawee S, Groszmann RJ, Garcia-Tsao G. The interpretation of hepatic venous pressure gradient tracings – excellent interobserver agreement unrelated to experience. Liver International 2016, 36: 1160-1166. PMID: 26763558, DOI: 10.1111/liv.13065.Peer-Reviewed Original ResearchConceptsHepatic venous pressure gradientIntraclass correlation coefficientPortal hypertensionBaseline hepatic venous pressure gradientObserver readingsInterobserver agreementVenous pressure gradientTherapy of patientsBland-Altman plotsPearson's linear regressionSingle centerBland-Altman techniqueCirrhosisLogistic regressionMean differencePatientsHypertensionMmHgExperienced observersResearch settingsPredictorsFurther supportSignificant linear relationshipLinear regressionHepatologists